GH Research PLC reported positive final results from its Phase 1 trial of the GH001 Aerosol Delivery System, supporting a simplified single-dose treatment for depression. The company received encouraging initial feedback from the FDA and plans to initiate pivotal trials for treatment-resistant depression (TRD) in early 2027 and postpartum depression (PPD) in the second half of 2027. Financially, GH Research ended Q3 2026 with $350.6 million in cash and securities, showing a net loss of $12.5 million for the quarter. The appointment of Dr. Vanina Popova as Chief Development Officer aims to strengthen clinical development efforts as the company moves toward regulatory milestones.
GH Research's recent Q3 2026 financial results and business update provide context for readers interested in health-related developments. For readers following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 19:41 WIB: out of 150 priced US health stocks tradable on Pluang, 99 rose and 43 fell today. Notable movers include NVAX at USD 8.96 with a 1-day change of +2.28% and a typical hold time of 60 days, COO at USD 63.52 with a +2.14% change and a 12-day hold time, and TVTX at USD 52.57 with a +1.96% change and a 9-day hold time. The most notable figure is NVAX's 99% buy order activity on Pluang.
Michelin has announced the total number of its voting rights and shares as of October 31, 2026. The company has 691,516,292 shares and 960,075,649 voting rights, considering 20,287,710 treasury shares. This disclosure complies with French regulations...
Michelin has disclosed the total number of voting rights and shares composing its capital as of October 31, 2026. The company reported 691,516,292 shares, with theoretical voting rights totaling 980,363,359 and exercisable voting rights at 960,075,64...
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
